BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mansour AM, Lima LH, Arevalo JF, Amaro MH, Lozano V, Ghannam AB, Chan EW. Retinal findings in membranoproliferative glomerulonephritis. Am J Ophthalmol Case Rep 2017;7:83-90. [PMID: 29260086 DOI: 10.1016/j.ajoc.2017.06.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Mack HG, Colville DJ, Harraka P, Savige JA, Invernizzi A, Fraser-Bell S. Retinal findings in glomerulonephritis. Clin Exp Optom 2021;:1-13. [PMID: 34877922 DOI: 10.1080/08164622.2021.2003691] [Reference Citation Analysis]
2 Tanner A, Chan HW, Stears A, Moosajee M. Bilateral macular drusen in acquired partial lipodystrophy with type 2 membranoproliferative glomerulonephritis. BMJ Case Rep 2021;14:e241666. [PMID: 34155011 DOI: 10.1136/bcr-2021-241666] [Reference Citation Analysis]
3 Nicolai M, Franceschi A, Lassandro NV, Pelliccioni P, Danieli L, Pirani V, Mariotti C. Retinal obliterative vasculitis associated to contralateral retinal neovascularization in membranoproliferative glomerulonephritis. Eur J Ophthalmol 2021;:11206721211014384. [PMID: 33938315 DOI: 10.1177/11206721211014384] [Reference Citation Analysis]
4 Parameswarappa DC, Rani PK. Utility of pattern recognition and multimodal imaging in the diagnosis and management of doyne honeycomb retinal dystrophy complicated with type one choroidal neovascular membrane. BMJ Case Rep 2021;14:e237635. [PMID: 33526522 DOI: 10.1136/bcr-2020-237635] [Reference Citation Analysis]
5 Paez-Escamilla M, Jhingan M, Gallagher DS, Singh SR, Fraser-Bell S, Chhablani J. Age-related macular degeneration masqueraders: From the obvious to the obscure. Surv Ophthalmol 2021;66:153-82. [PMID: 32971140 DOI: 10.1016/j.survophthal.2020.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Gambato T, Francescutti L, Lanzetta P. Choroidal Neovascularization in Primary Membranous Nephropathy. Am J Case Rep 2020;21:e923454. [PMID: 32649651 DOI: 10.12659/AJCR.923454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Murro V, Mucciolo DP, Giorgio D, Sodi A, Passerini I, Pacini B, Finocchio L, Virgili G, Rizzo S. Multimodal imaging of benign yellow dot maculopathy. Ophthalmic Genet 2019;40:135-40. [PMID: 30942106 DOI: 10.1080/13816810.2019.1589529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Braga J, Rothwell R, Oliveira M, Rodrigues D, Fonseca S, Varandas R, Ribeiro L. Choroid thickness profile in patients with lupus nephritis. Lupus 2019;28:475-82. [PMID: 30755143 DOI: 10.1177/0961203319828525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
9 de-Pablo-Gómez-de-Liaño L, Cañas Zamarra I, Fernández-vigo J, Fernández Vidal M, Navarro-perea C, Cavero Escribano T. Manifestaciones retinianas en pacientes con glomerulonefritis membranoproliferativa mediada por complemento. Archivos de la Sociedad Española de Oftalmología 2019;94:95-99. [DOI: 10.1016/j.oftal.2018.06.013] [Reference Citation Analysis]
10 de-Pablo-Gómez-de-Liaño L, Cañas Zamarra I, Fernández-vigo J, Fernández Vidal M, Navarro-perea C, Cavero Escribano T. Retinal manifestations in patients with complement-mediated membranoproliferative glomerulonephritis. Archivos de la Sociedad Española de Oftalmología (English Edition) 2019;94:95-99. [DOI: 10.1016/j.oftale.2018.11.001] [Reference Citation Analysis]